opentargets-database

Open Targets Database - Drug Target Discovery and Validation Platform

Skills Overview

Open Targets Database is an integrated resource platform for systematically identifying and prioritizing potential therapeutic drug targets. It combines human genetics, omics, literature, and chemical data to help researchers with target discovery, druggability assessment, and drug repurposing analyses.

Applicable Scenarios

1. Drug Target Discovery and Validation

When a research team needs to find potential therapeutic targets for a specific disease, they can use this skill to query disease–target associations and obtain multi-dimensional supporting data such as genetic evidence and pathway evidence. The system provides an aggregated score for each association to help researchers quickly filter high-priority targets.

2. Target Druggability and Safety Assessment

After selecting candidate targets, this skill can be used to assess the gene’s druggability (predicted developability for small molecules, antibodies, PROTACs, etc.) and safety risks. The system integrates safety liability information from multiple databases and genetic constraint scores from gnomAD to comprehensively evaluate the therapeutic window of targets.

3. Drug Repurposing and Competitive Intelligence

This skill supports finding known drugs related to a disease and their mechanisms of action, understanding clinical trial phases and development status to provide clues for drug repurposing. It also allows queries about competitors’ target portfolios, clinical precedents, and drug development progress.

Core Functions

1. Multi-entity Intelligent Search

Supports quick lookup of corresponding Ensembl gene IDs, EFO disease IDs, and ChEMBL drug IDs by gene name, disease name, or drug name. The fuzzy search feature lets users locate entities using common names without memorizing complex identifiers.

2. Target–Disease Association Queries

Retrieve aggregated association scores for target–disease pairs and break down evidence sources by data type (genetic associations, somatic mutations, known drugs, pathway impact, RNA expression, animal models, literature mining, etc.). Each evidence record includes the data source, score, original study identifiers, and associated publications.

3. Target Annotation Retrieval

Query detailed annotation information for genes, including:

Druggability assessment: predicted developability for different modalities such as small molecules, antibodies, and PROTACs

Safety risks: known toxicity concerns from multiple databases

Genetic constraint: gnomAD pLI and LOEUF scores indicating gene essentiality

Expression profile data: tissue and cell-type expression patterns

Disease associations: list of associated diseases ranked by score

4. Drug and Indication Information

Obtain detailed development information for drugs, including maximum clinical trial phase, mechanism of action, list of indications, trial status, and (where applicable) reasons for withdrawal and countries. Supports querying all drugs related to a disease and their targets.

5. Direct GraphQL API Access

Provides convenient helper functions for common queries and also supports direct use of the GraphQL API for custom complex queries. No authentication is required; all data is publicly accessible and pagination is supported for large result sets.

Frequently Asked Questions

What is Open Targets Database and what can it do?

Open Targets Database is a therapeutic target identification platform that integrates human genetics, genomics, literature, and chemical data. It helps researchers discover disease-associated genes, assess target druggability and safety, query known drugs and mechanisms of action, retrieve supporting evidence, and perform competitive intelligence analysis. The platform provides data access via GraphQL API, web interface, data downloads, and Google BigQuery.

How do I query therapeutic target information for a gene?

First use the search_entities() function to search the gene name (e.g., "BRCA1") to obtain the Ensembl ID, then call get_target_info() to get full annotation. If you need to view the association evidence between that gene and a specific disease, use get_target_disease_evidence(), and you can filter results by data type (e.g., genetic association, known drugs). All queries can be performed using the provided helper functions or directly via the GraphQL API for custom queries.

How should I interpret Open Targets’ association scores?

Association scores range from 0 to 1; higher scores indicate stronger supporting evidence for the target–disease association. Scores are aggregated across all evidence types using a harmonic mean and are a relative ranking metric rather than a confidence measure. Note that scores are influenced by the extent of research on a disease—less-studied diseases may have good-quality evidence but lower scores. It is recommended to review the detailed breakdown of evidence types, with particular attention to human genetic evidence (especially GWAS L2G > 0.5) and clinical precedents (approved drugs). Multiple independent evidence sources, high-scoring genetic associations, and the presence of clinical precedents are all indicators of strong evidence.